NAMSW NewAmsterdam Pharma Company N.V. - Warrant
NASDAQ · Visualizza su SEC EDGAR ↗ chiudi Ott 1, 2026 10-K/10-Q Feb 18, 2026
$12,65
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$11,37minimo 52 sett.
$30,45massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1.45B
P/E (TTM)
-7.4
EPS (TTM)
$-1.72
Ricavi (TTM)
$23M
i tuoi badge
Intervallo 52 sett.
$11–$30
Rating Analisti
·
Prezzo Obiettivo
·
P/E
-7.4
ROE
-28.3%
Margine di Profitto Netto
-905.7%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
NAMSW Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$12.65
Capitalizzazione di Mercato (MRQ)
$1.45B
P/E (TTM)
-7.4
EPS (TTM)
$-1.72
Ricavi (TTM)
$23M
ROE (TTM)
-28.3%
Intervallo 52 sett.
$11–$30
NAMSW Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$23M2022-12-31 → 2025-12-31
EPS$-1.722020-12-31 → 2025-12-31
Flusso di cassa libero$-148M2022-12-31 → 2025-12-31
Margine netto-905.7%2023-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | NAMSW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -7.4media 5 anni ≈-5.3 | ≈-5.3 | · | · | |
| P/S (TTM) | 64.3media 5 anni ≈56.3 | ≈56.3 | · | · | |
| P/B (MRQ) | 2.1media 5 anni ≈2.3 | ≈2.3 | · | · | |
| Prezzo / FCF (TTM) | -9.8media 5 anni ≈-9.8 | ≈-9.8 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -9.8media 5 anni ≈-9.8 | ≈-9.8 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 2.1media 5 anni ≈2.3 | ≈2.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | NAMSW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -1002.9%media 5 anni ≈-896.1% | ≈-896.1% | · | · | |
| Margine EBITDA (TTM) | -1001.9%media 5 anni ≈-895.6% | ≈-895.6% | · | · | |
| Margine ante imposte (TTM) | -905.7%media 5 anni ≈-897.2% | ≈-897.2% | · | · | |
| Margine di Profitto Netto (TTM) | -905.7%media 5 anni ≈-897.2% | ≈-897.2% | · | · | |
| ROA (TTM) | -24.9%media 5 anni ≈-33.5% | ≈-33.5% | · | · | |
| ROE (TTM) | -28.3%media 5 anni ≈-42.4% | ≈-42.4% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | NAMSW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 7.9media 5 anni ≈8.9 | ≈8.9 | · | · | |
| Quick Ratio | 7.4media 5 anni ≈8.6 | ≈8.6 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | NAMSW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -50.6%media 5 anni ≈28.8% | ≈28.8% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -39.7% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | NAMSW | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$225.0K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $23M | $46M | $14M | $103M | |
| R&D Expense | $142M | $151M | $159M | $87M | |
| SG&A Expense | $106M | $70M | $38M | $20M | |
| Operating Expenses | $248M | $222M | $197M | $106M | |
| Operating Income | $-226M | $-176M | $-183M | $-4M | |
| Interest Expense | · | · | · | $287.0K | |
| Interest Income | $28M | $17M | $11M | $11.0K | |
| Pretax Income | $-204M | $-242M | $-177M | $-23M | |
| Income Tax | · | $-1.0K | $27.0K | · | |
| Net Income | $-204M | $-242M | $-177M | $-23M | |
| EPS (Basic) | $-1.72 | $-2.56 | $-2.15 | $-1.19 | |
| EPS (Diluted) | $-1.72 | $-2.56 | $-2.15 | $-1.19 | |
| Shares (Basic) | 118,424,231 | 94,358,067 | 82,161,956 | 18,966,235 | |
| Shares (Diluted) | 118,424,231 | 94,358,067 | 82,161,956 | 18,966,235 | |
| EBITDA | $-225M | $-176M | $-183M | $-67M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $490M | $772M | $340M | $439M | |
| Short-term Investments | $146M | $62M | · | · | |
| Prepaid Expense | $38M | $24M | $6M | $10M | |
| Current Assets | $676M | $863M | $347M | $448M | |
| PP&E (Net) | $383.0K | $242.0K | $46.0K | $144.0K | |
| Intangibles | · | · | · | $83M | |
| Total Assets | $769M | $865M | $347M | $532M | |
| Accounts Payable | $9M | $5M | $17M | $19M | |
| Current Liabilities | $86M | $107M | $50M | $35M | |
| Capital Leases | $66.0K | $202.0K | · | $60.0K | |
| Total Liabilities | $86M | $107M | $59M | $48M | |
| Common Stock | $14M | $13M | $10M | $10M | |
| Retained Earnings | $-762M | $-559M | $-317M | $-140M | |
| AOCI | $5M | $4M | $4M | $4M | |
| Stockholders' Equity | $683M | $758M | $288M | $430M | |
| Liabilities + Equity | $769M | $865M | $347M | $478M | |
| Shares Outstanding | 114,399,326 | 108,064,340 | 82,469,768 | 81,559,780 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $220.0K | $113.0K | $49.0K | $9.0K | |
| Stock-based Comp | $59M | $34M | $25M | $4M | |
| Other Non-cash | $-4M | $49M | $11M | $86M | |
| Operating Cash Flow | $-148M | $-159M | $-141M | $11M | |
| CapEx | $246.0K | $672.0K | $24.0K | $221.0K | |
| Investing Cash Flow | $-175M | $-63M | $-24.0K | $-221.0K | |
| Financing Cash Flow | $30M | $660M | $9M | $392M | |
| Free Cash Flow | $-148M | $-159M | $-141M | $8M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -1002.9% | -386.9% | -1298.6% | · | |
| Net Margin | -905.7% | -530.2% | -1255.8% | · | |
| Pretax Margin | -905.7% | -530.2% | -1255.6% | · | |
| EBITDA Margin | -1001.9% | -386.7% | -1298.2% | · | |
| ROA | -24.9% | -39.9% | -42.9% | -26.4% | |
| ROE | -27.9% | -42.5% | -57.1% | -42.1% | |
| ROIC | · | -23.3% | -63.4% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.1 | 7.0 | 12.6 | |
| Quick Ratio | 7.4 | 7.8 | 6.8 | 12.4 | |
| Interest Coverage | · | · | · | -249.3 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $5.97 | $7.01 | $3.50 | · | |
| Revenue / Share | $0.19 | $0.48 | $0.17 | · | |
| Cash Flow / Share | $-1.25 | $-1.68 | $-1.72 | · | |
| Cash / Share | $4.28 | $7.14 | $4.13 | · | |
| EPS (TTM) | $-1.72 | $-2.56 | $-2.15 | $-1.19 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -50.6% | 223.4% | -86.3% | · | |
| Revenue CAGR 3Y | -39.7% | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $23M | $46M | $14M | $103M | |
| Net Income TTM | $-204M | $-242M | $-177M | $-23M | |
| Market Cap | $2.63B | $1.54B | $258M | · | |
| P/E | -13.4 | -5.6 | -1.5 | -0.7 | |
| P/S | 116.9 | 33.8 | 18.3 | · | |
| P/B | 3.9 | 2.0 | 0.9 | · | |
| P / Tangible Book | 3.9 | 2.0 | 0.9 | · | |
| P / Cash Flow | -17.8 | -9.7 | -1.8 | · | |
| P / FCF | -17.8 | -9.7 | -1.8 | · | |
| Earnings Yield | -7.5% | -18.0% | -68.7% | -137.1% |
Conto Economico
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.0K | $348.0K | $19M | $3M | $13M | $29M | $2M | $1M | $3M | $2M | $9M | |
| R&D Expense | $39M | $31M | $28M | $45M | $35M | $36M | $38M | $42M | $43M | $34M | $40M | |
| SG&A Expense | $27M | $25M | $27M | $27M | $21M | $18M | $16M | $14M | $9M | $10M | $8M | |
| Operating Expenses | $66M | $55M | $55M | $72M | $56M | $54M | $55M | $57M | $52M | $44M | $48M | |
| Operating Income | $-66M | $-55M | $-36M | $-69M | $-43M | $-25M | $-53M | $-55M | $-50M | $-42M | $-40M | |
| Interest Income | $6M | $7M | $7M | $7M | $4M | $4M | $5M | $3M | $3M | $5M | $943.0K | |
| Pretax Income | $-75M | $-72M | $-17M | $-40M | $-92M | $-17M | $-39M | $-94M | $-47M | $-38M | $-42M | |
| Income Tax | · | · | · | · | $0 | $-1.0K | · | · | · | · | · | |
| Net Income | $-75M | $-72M | $-17M | $-40M | $-92M | $-17M | $-39M | $-94M | $-47M | $-38M | $-42M | |
| EPS (Basic) | $-0.62 | $-0.61 | $-0.15 | $-0.34 | $-0.91 | $-0.18 | $-0.41 | $-1.06 | $-0.57 | $-0.47 | $-0.51 | |
| EPS (Diluted) | $-0.62 | $-0.61 | $-0.15 | $-0.34 | $-0.91 | $-0.18 | $-0.41 | $-1.06 | $-0.57 | $-0.47 | $-0.51 | |
| Shares (Basic) | · | 119,000,266 | 118,556,492 | 116,124,941 | · | 94,754,140 | 94,711,604 | 88,380,230 | 82,466,584 | 82,064,519 | 81,634,428 | |
| Shares (Diluted) | · | 119,000,266 | 118,556,492 | 116,124,941 | · | 94,754,140 | 94,711,604 | 88,380,230 | 82,466,584 | 82,064,519 | 81,634,428 | |
| EBITDA | · | $-55M | $-36M | $-69M | · | $-25M | $-53M | $-55M | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $490M | $538M | $564M | $748M | $772M | $423M | $431M | $481M | · | · | · | |
| Short-term Investments | $146M | $165M | $175M | $60M | $62M | · | · | · | · | · | · | |
| Prepaid Expense | $38M | $28M | $31M | $9M | $24M | $15M | $15M | $7M | · | · | · | |
| Current Assets | $676M | $732M | $770M | $817M | $863M | $438M | $445M | $488M | · | · | · | |
| PP&E (Net) | $383.0K | $323.0K | $312.0K | $238.0K | $242.0K | $231.0K | $234.0K | $101.0K | · | · | · | |
| Total Assets | $769M | $786M | $815M | $818M | $865M | $439M | $447M | $488M | · | · | · | |
| Accounts Payable | $9M | $4M | $6M | $6M | $5M | $7M | $5M | $9M | · | · | · | |
| Current Liabilities | $86M | $58M | $37M | $41M | $107M | $41M | $45M | $60M | · | · | · | |
| Capital Leases | $66.0K | $85.0K | $103.0K | $137.0K | $202.0K | $266.0K | $328.0K | · | · | · | · | |
| Total Liabilities | $86M | $58M | $37M | $41M | $107M | $60M | $59M | $77M | · | · | · | |
| Common Stock | $14M | $14M | $14M | $14M | $13M | $11M | $11M | $11M | · | · | · | |
| Retained Earnings | $-762M | $-687M | $-615M | $-598M | $-559M | $-466M | $-450M | $-411M | · | · | · | |
| AOCI | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | · | · | · | |
| Stockholders' Equity | $683M | $728M | $778M | $777M | $758M | $379M | $387M | $412M | · | · | · | |
| Liabilities + Equity | $769M | $786M | $815M | $818M | $865M | $439M | $447M | $488M | · | · | · | |
| Shares Outstanding | 114,399,326 | 113,172,684 | 112,509,914 | 112,169,291 | 108,064,340 | 92,165,605 | 90,015,357 | 89,720,836 | · | · | · |
Flusso di cassa
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $59.0K | $64.0K | $45.0K | $52.0K | $51.0K | $28.0K | $19.0K | $15.0K | $14.0K | $13.0K | $9.0K | |
| Stock-based Comp | $14M | $15M | $15M | $15M | $9M | $8M | $8M | $8M | $5M | $6M | $8M | |
| Other Non-cash | · | · | · | $-12M | · | · | · | $31M | · | · | · | |
| Operating Cash Flow | $-41M | $-33M | $-38M | $-36M | $-37M | $-13M | $-54M | $-55M | $-47M | $-29M | $-32M | |
| CapEx | $100.0K | $42.0K | $88.0K | $16.0K | $3.0K | $75.0K | $209.0K | $385.0K | $9.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $-21M | $3M | $-159M | $3M | $-62M | $-75.0K | $-209.0K | $-385.0K | $-9.0K | $-5.0K | $-7.0K | |
| Financing Cash Flow | $14M | $6M | $3M | $7M | $457M | $58.0K | $5M | $198M | $186.0K | $6M | $2M | |
| Free Cash Flow | · | · | · | $-36M | · | · | · | $-55M | · | · | · |
Redditività
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -15845.7% | -186.1% | -2314.5% | · | -85.9% | -2306.9% | -3960.2% | · | · | · | |
| Net Margin | · | -20691.1% | -90.7% | -1327.3% | · | -57.2% | -1711.6% | -6692.9% | · | · | · | |
| Pretax Margin | · | -20691.1% | -90.7% | -1327.3% | · | -57.2% | -1711.6% | -6692.9% | · | · | · | |
| EBITDA Margin | · | -15845.7% | -186.1% | -2312.7% | · | -85.9% | -2306.9% | -3959.1% | · | · | · | |
| ROA | · | -11.8% | -2.8% | -6.0% | · | -7.6% | -17.5% | -38.4% | · | · | · | |
| ROE | · | -13.0% | -3.0% | -6.7% | · | -8.8% | -20.1% | -45.5% | · | · | · | |
| ROIC | · | · | · | · | · | -6.6% | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 12.6 | 21.1 | 20.0 | · | 10.6 | 9.8 | 8.2 | · | · | · | |
| Quick Ratio | · | 12.1 | 20.2 | 19.8 | · | 10.2 | 9.5 | 8.1 | · | · | · |
Efficienza
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | · | · |
Per Azione
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $6.43 | $6.92 | $6.93 | · | $4.11 | $4.30 | $4.59 | · | · | · | |
| Revenue / Share | · | $0.00 | $0.16 | $0.03 | · | $0.31 | $0.02 | $0.02 | · | · | · | |
| Cash Flow / Share | · | · | · | $-0.31 | · | · | · | $-0.62 | · | · | · | |
| Cash / Share | · | $4.76 | $5.01 | $6.67 | · | $4.59 | $4.78 | $5.36 | · | · | · | |
| EPS (TTM) | · | $-2.01 | $-1.58 | $-1.84 | · | $-2.25 | $-2.64 | $-2.70 | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $35M | $64M | $47M | · | $34M | $7M | $7M | · | · | · | |
| Net Income TTM | · | $-221M | $-166M | $-187M | · | $-199M | $-229M | $-229M | · | · | · | |
| Market Cap | · | $1.94B | $900M | $1.01B | · | $645M | $785M | $991M | · | · | · | |
| P/E | · | -8.5 | -5.1 | -4.9 | · | -3.1 | -3.3 | -4.1 | · | · | · | |
| P/S | · | 54.9 | 14.1 | 21.4 | · | 19.2 | 105.7 | 144.3 | · | · | · | |
| P/B | · | 2.7 | 1.2 | 1.3 | · | 1.7 | 2.0 | 2.4 | · | · | · | |
| P / Tangible Book | · | 2.7 | 1.2 | 1.3 | · | 1.7 | 2.0 | 2.4 | · | · | · | |
| P / Cash Flow | · | · | · | -27.7 | · | · | · | -18.1 | · | · | · | |
| Earnings Yield | · | -11.8% | -19.8% | -20.5% | · | -32.1% | -30.3% | -24.5% | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $23M | $46M | $14M | $103M | · |
| Margine Operativo % | -1002.9% | -386.9% | -1298.6% | · | · |
| Utile netto | $-204M | $-242M | $-177M | $-23M | $-29M |
| EPS Diluito | $-1.72 | $-2.56 | $-2.15 | $-1.19 | $-1.21 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 7.9 | 8.1 | 7.0 | 12.6 | · |
| Quick Ratio | 7.4 | 7.8 | 6.8 | 12.4 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-148M | $-159M | $-141M | $8M | · |
Proprietari istituzionali (13F) 11 filer · $29.6M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
11
Valore detenuto
$29.6M
Nuove posizioni
0
Posizioni chiuse
0
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 0 (-1 vs trimestre precedente) | 0 (0 vs trimestre precedente) | 2 (+2 vs trimestre precedente) | 0 (-1 vs trimestre precedente) | +13K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $10.692.116 | 500.333 | 36,15% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $7.123.326 | 333.333 | 24,09% | Azioni |
| Affinity Asset Advisors, LLC | $5.343.450 | 245.000 | 18,07% | Azioni |
| Bain Capital Life Sciences Investors, LLC | $2.136.979 | 99.999 | 7,23% | Azioni |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $1.982.858 | 92.787 | 6,70% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.602.750 | 75.000 | 5,42% | Opzione Call |
| ARISTEIA CAPITAL, L.L.C. | $343.377 | 15.708 | 1,16% | Azioni |
| WOLVERINE ASSET MANAGEMENT LLC | $318.947 | 14.925 | 1,08% | Azioni |
| CIBC Private Wealth Group LLC | $22.388 | 1.250 | 0,08% | Azioni |
| UBS Group AG | $8.523 | 443 | 0,03% | Azioni |
| Vestcor Inc | $143 | 6.666 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| FHMLS X, L.L.C., FHMLS X, L.P., FHMLS XI, L.L.C., FHMLS XI, L.P., FHMLS XII, L.L.C., FHMLS XII, L.P., FHMLSP, L.L.C., FHMLSP, L.P., Frazier Life Sciences Public Fund, L.P., Frazier Life Sciences X, L.P., Frazier Life Sciences XI, L.P., Frazier Life Sciences XII, L.P., Frazier Lifesciences Sponsor LLC, James N. Topper, Patrick J. Heron | 22 Settembre 2026 | 8,70% | Modifica | · | SEC |
| BCLS Fund III Investments, LP, Bain Capital Life Sciences Opportunities III, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCLS II Equity Opportunities, LP, BCIP Life Sciences Associates, LP | 14 Maggio 2026 | 1,76% | Modifica | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 5 insider · 4 dirigenti · 3 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael H. Davidson | Chief Executive Officer | 14 Settembre 2026 P | 792.923 | 1 | 0 | $226.500 |
| Johannes Jacob Pieter Kastelein | Chief Scientific Officer | 30 Settembre 2026 M | 69.302 | 0 | 2 | $-4.621.407 |
| Robert William Gunning | Vice President, Controller | 01 Settembre 2026 A | 3.200 | 0 | 0 | $0 |
| Louise Frederika Kooij | Chief Accounting Officer | 20 Luglio 2026 M | 24.353 | 0 | 5 | $-4.393.815 |
| John W Smither | Direttore | 04 Settembre 2026 S | 8.760 | 0 | 1 | $-40.512 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-K depositato Feb 18, 2026